BioAge Labs (BIOA) Non Operating Interest Expenses (2023 - 2026)

BioAge Labs has disclosed Non Operating Interest Expenses across 4 years of filings, most recently posting $1000.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses fell 99.5% year-over-year to $1000.0; the TTM figure through Jun 2026 stood at $281000.0 (down 75.84% YoY), while the FY2025 annual figure was $697000.0, down 70.55% from the prior year.
• Non Operating Interest Expenses came in at $1000.0 for Q2 2026 at BioAge Labs, down from $39000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $2.6 million in Q4 2023 to a low of $1000.0 in Q2 2026.
• Average Non Operating Interest Expenses over 4 years is $672166.7, with a median of $287000.0 recorded in 2024.
• Year-over-year, Non Operating Interest Expenses sank 54.63% in 2025 and slumped 99.5% in 2026.
• Over 4 years, Non Operating Interest Expenses stood at $2.6 million in 2023, then plunged by 87.53% to $319000.0 in 2024, then plunged by 71.16% to $92000.0 in 2025, then tumbled by 98.91% to $1000.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $1000.0 in Q2 2026, $39000.0 in Q1 2026, and $92000.0 in Q4 2025.